TY  - JOUR

T1  - Adjuvant zoledronic acid (ZOL) in postmenopausal women with breast cancer and those rendered postmenopausal: Results of a meta-analysis.

JO  - Journal of Clinical Oncology

PY  - 2012/05/20

AU  - Gregory W

AU  - Marshall H

AU  - Bell R

AU  - Cameron DA

AU  - Coleman RE

ED  - 

DO  - DOI: 10.1200/jco.2012.30.15_suppl.513

PB  - American Society of Clinical Oncology (ASCO)

VL  - 30

IS  - 15_suppl

SP  - 513

EP  - 513

Y2  - 2025/10/10

ER  -